Voriconazole Injection, Powder, Lyophilized, For Solution
Product Images NDC 70594-067

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Voriconazole (NDC 70594-067). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Xellia Pharmaceuticals Usa Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Voriconazole 01)

FDA Label Image

Principal Display Panel (200 MG Vial Label)

Principal Display Panel (200 MG Vial Label)
This is a prescription-only medication with the generic name Voriconazole used for injection. It is a clear solution containing 40 mg/ml voriconazole, which must be reconstituted with 19 mL of water for injection before use. The medication comes in a sterile single-dose vial that should be discarded if any solutions remain unused. The recommended intravenous dosage and dilution should be referred to from the prescribing information. Each vial contains 200 mg of the active ingredient, HPRCD500, and is made in India for Xellia Pharmaceuticals USA, LLC. The drug product doesn't contain natural rubber latex or any preservatives. The storage temperature for this medication is 20°C to 25°C (68°F to 77°F). The provided code number is APDRUGS/103/97, but the Lot number for the specific product is missing.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.